Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL
tel-00827710, version 1 - 29 May 2013 characterized in mice as well as in humans. pDCs are strongly implicated in innate immunity due to their capacity to secrete high amounts of type I Interferons (IFN) and, in some studies, demonstrated ability to present antigen (Villadangos and Young, 2008). However, for the remainder of this introduction, I will focus on cDCs. Collectively, cDCs is an heterogeneous group of DCs that can be divided into the broad groupings of lymphoid tissue-resident DCs and peripheral, migratory DCs (Heath and Carbone, 2009). In the spleen, 3 further cDC subsets have been described based on CD8 and CD4 expression: the CD8α + DCs, the CD8α - DCs and the double negative DCs (Vremec et al., 2000). However in draining lymph nodes, other subsets can be observed that correspond to the migratory DC populations that reside in tissue and have the ability to migrate to lymphoid organs upon activation. Using the skin- draining lymph node as an example, 3 additional subsets are found: the Langherans cells that are normally found in the epidermis, the classical dermal CD11b + CD103 - DCs, and the dermal CD11b low CD103 + DCs (Ginhoux et al., 2007). Interestingly the 2 subsets CD11b + CD103 - DCs, and the CD11b low CD103 + DCs are also found in other peripheral tissues such as the lung (Sung et al., 2006) and the gut (Annacker et al., 2005) where they seem to have the same specialized function, regulating the immune response. In contrast, the Langherans cells are specific to the skin. An additional subset that is not present at steady state, but that appears under conditions of inflammation is the inflammatory monocyte-derived DCs. 36
tel-00827710, version 1 - 29 May 2013 Table 4. Mouse DC subsets. Mono-DC, Monocyte-derived DC; LC, Langherans cell. (*) This subset was shown to respond to poly I:C but TLR3 was not identified in these cells. 2) Specialization (a) Ability to present antigen The different cDC subsets have been described to have various abilities for antigen uptake and presentation. The CD8α + DCs showed a superior capacity to take up dying cells (Iyoda et al., 2002), which is correlated with their relatively increased expression of some receptors known for clearance of dead cells, such as Clec9A. Moreover this subset has been demonstrated to better cross-present antigen compared to the CD8α - DC subset from the Page 37 of 256
- Page 1 and 2: tel-00827710, version 1 - 29 May 20
- Page 3 and 4: tel-00827710, version 1 - 29 May 20
- Page 5 and 6: tel-00827710, version 1 - 29 May 20
- Page 7 and 8: tel-00827710, version 1 - 29 May 20
- Page 9 and 10: tel-00827710, version 1 - 29 May 20
- Page 11 and 12: tel-00827710, version 1 - 29 May 20
- Page 13 and 14: tel-00827710, version 1 - 29 May 20
- Page 15 and 16: tel-00827710, version 1 - 29 May 20
- Page 17 and 18: tel-00827710, version 1 - 29 May 20
- Page 19 and 20: tel-00827710, version 1 - 29 May 20
- Page 21 and 22: tel-00827710, version 1 - 29 May 20
- Page 23 and 24: tel-00827710, version 1 - 29 May 20
- Page 25 and 26: tel-00827710, version 1 - 29 May 20
- Page 27 and 28: tel-00827710, version 1 - 29 May 20
- Page 29 and 30: tel-00827710, version 1 - 29 May 20
- Page 31 and 32: tel-00827710, version 1 - 29 May 20
- Page 33 and 34: tel-00827710, version 1 - 29 May 20
- Page 35: tel-00827710, version 1 - 29 May 20
- Page 39 and 40: tel-00827710, version 1 - 29 May 20
- Page 41 and 42: tel-00827710, version 1 - 29 May 20
- Page 43 and 44: tel-00827710, version 1 - 29 May 20
- Page 45 and 46: tel-00827710, version 1 - 29 May 20
- Page 47 and 48: tel-00827710, version 1 - 29 May 20
- Page 49 and 50: tel-00827710, version 1 - 29 May 20
- Page 51 and 52: tel-00827710, version 1 - 29 May 20
- Page 53 and 54: tel-00827710, version 1 - 29 May 20
- Page 55 and 56: tel-00827710, version 1 - 29 May 20
- Page 57 and 58: tel-00827710, version 1 - 29 May 20
- Page 59 and 60: tel-00827710, version 1 - 29 May 20
- Page 61 and 62: tel-00827710, version 1 - 29 May 20
- Page 63 and 64: tel-00827710, version 1 - 29 May 20
- Page 65 and 66: tel-00827710, version 1 - 29 May 20
- Page 67 and 68: tel-00827710, version 1 - 29 May 20
- Page 69 and 70: tel-00827710, version 1 - 29 May 20
- Page 71 and 72: tel-00827710, version 1 - 29 May 20
- Page 73 and 74: tel-00827710, version 1 - 29 May 20
- Page 75 and 76: tel-00827710, version 1 - 29 May 20
- Page 77 and 78: tel-00827710, version 1 - 29 May 20
- Page 79 and 80: tel-00827710, version 1 - 29 May 20
- Page 81 and 82: tel-00827710, version 1 - 29 May 20
- Page 83 and 84: tel-00827710, version 1 - 29 May 20
- Page 85 and 86: tel-00827710, version 1 - 29 May 20
tel-00827710, version 1 - 29 May 2013<br />
characterized in mice as well as in humans. pDCs are strongly implicated in innate immunity<br />
due to their capacity to secr<strong>et</strong>e high amounts of type I Interferons (IFN) and, in some studies,<br />
<strong>de</strong>monstrated ability to present antigen (Villadangos and Young, 2008). However, for the<br />
remain<strong>de</strong>r of this introduction, I will focus on cDCs. Collectively, cDCs is an h<strong>et</strong>erogeneous<br />
group of DCs that can be divi<strong>de</strong>d into the broad groupings of lymphoid tissue-resi<strong>de</strong>nt DCs<br />
and peripheral, migratory DCs (Heath and Carbone, 2009). In the spleen, 3 further cDC<br />
subs<strong>et</strong>s have been <strong>de</strong>scribed based on CD8 and CD4 expression: the CD8α + DCs, the CD8α -<br />
DCs and the double negative DCs (Vremec <strong>et</strong> al., 2000). However in draining lymph no<strong>de</strong>s,<br />
other subs<strong>et</strong>s can be observed that correspond to the migratory DC populations that resi<strong>de</strong> in<br />
tissue and have the ability to migrate to lymphoid organs upon activation. Using the skin-<br />
draining lymph no<strong>de</strong> as an example, 3 additional subs<strong>et</strong>s are found: the Langherans cells that<br />
are normally found in the epi<strong>de</strong>rmis, the classical <strong>de</strong>rmal CD11b + CD103 - DCs, and the<br />
<strong>de</strong>rmal CD11b low CD103 + DCs (Ginhoux <strong>et</strong> al., 2007). Interestingly the 2 subs<strong>et</strong>s CD11b +<br />
CD103 - DCs, and the CD11b low CD103 + DCs are also found in other peripheral tissues such as<br />
the lung (Sung <strong>et</strong> al., 2006) and the gut (Annacker <strong>et</strong> al., 2005) where they seem to have the<br />
same specialized function, regulating the immune response. In contrast, the Langherans cells<br />
are specific to the skin. An additional subs<strong>et</strong> that is not present at steady state, but that appears<br />
un<strong>de</strong>r conditions of inflammation is the inflammatory monocyte-<strong>de</strong>rived DCs.<br />
36